Inhibitory mechanisms and clinical applications of anticholinesterases.
Whittaker
V P
VP
Max-Planck-Institut für biophysikalische Chemie, Göttingen, Germany.
D000544:Alzheimer Disease / Q000188:drug therapy; D001342:Autonomic Nervous System Diseases / Q000188:drug therapy; D002384:Catalysis; D002800:Cholinesterase Inhibitors / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D002802:Cholinesterases / Q000145:classification / Q000235:genetics / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D009157:Myasthenia Gravis / Q000188:drug therapy; D009479:Neuropeptides / Q000502:physiology; D011110:Polymorphism, Genetic; D013379:Substrate Specificity
D002800:Cholinesterase Inhibitors; D009479:Neuropeptides; D002802:Cholinesterases